CSBR
Champions Oncology·NASDAQ
--
--(--)
--
--(--)
2.39 / 10
Underperform
Technically, CSBR is underperforming with a 2.39/10 score. Dominant bearish signals include the Long Lower Shadow and MACD Golden Cross, while the MACD Death Cross offers only modest bullish support. The preponderance of three bearish versus zero bullish indicators underscores a weak market trend, highlighting the need for caution and tight risk management for traders relying on technical analysis.
Analysis Checks(1/4)
Long Lower Shadow
Score1/10
Win Rate32.50%
Hist. Signals40
Avg Return-1.68%
Score1/10
Win Rate32.50%
Hist. Signals40
Avg Return-1.68%
MACD Golden Cross
Score1/10
Win Rate22.22%
Hist. Signals9
Avg Return-4.23%
Score1/10
Win Rate22.22%
Hist. Signals9
Avg Return-4.23%
MACD Death Cross
Score6.13/10
Win Rate55.56%
Hist. Signals9
Avg Return2.11%
Score6.13/10
Win Rate55.56%
Hist. Signals9
Avg Return2.11%
Marubozu White
Score1.42/10
Win Rate44.44%
Hist. Signals27
Avg Return-1.70%
Score1.42/10
Win Rate44.44%
Hist. Signals27
Avg Return-1.70%
Long Lower Shadow
Score1/10
Win Rate32.50%
Hist. Signals40
Avg Return-1.68%
Score1/10
Win Rate32.50%
Hist. Signals40
Avg Return-1.68%
MACD Death Cross
Score6.13/10
Win Rate55.56%
Hist. Signals9
Avg Return2.11%
Score6.13/10
Win Rate55.56%
Hist. Signals9
Avg Return2.11%
MACD Golden Cross
Score1/10
Win Rate22.22%
Hist. Signals9
Avg Return-4.23%
Score1/10
Win Rate22.22%
Hist. Signals9
Avg Return-4.23%
Marubozu White
Score1.42/10
Win Rate44.44%
Hist. Signals27
Avg Return-1.70%
Score1.42/10
Win Rate44.44%
Hist. Signals27
Avg Return-1.70%
What is the current technical signals for CSBR?
- CSBR presents a Underperform setup with a Technical Score of 2.39/10. Key technical indicators highlight an RSI of 41.55 and a MACD of -0.18, with the trend anchored by the 50-Day SMA at 6.79. Traders should monitor key support at 6.39 and resistance at 6.81.
